4.3 Review

Bisphenol A: A notorious player in the mosaic of autoimmunity

期刊

AUTOIMMUNITY
卷 51, 期 8, 页码 370-377

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1080/08916934.2018.1551374

关键词

Bisphenol A (BPA); autoimmunity; xenoestrogen; endocrine disrupting chemicals; plastic

向作者/读者索取更多资源

The multifactorial etiology of autoimmune diseases has been studied at large. Genetic risk factors and environmental agents play an integral role in the pathogenesis of autoimmune processes. In recent decades, Bisphenol A (BPA), an exogenous compound found in polycarbonate plastic, has gained attention for its harmful multifocal effects on a diverse subset of systemic pathways, potentially contributing to disease onset and exacerbation. BPA is a xenoestrogen used globally in the manufacture of daily use products including plastic storage containers, water and infant bottles, and food and drink packaging. BPA exhibits immune stimulatory activity bringing into question the association between its greater global presence and the increased prevalence of autoimmune diseases. The purpose of this multi-study analysis is to assess recent research investigating the underlying role of BPA in autoreactive mechanisms. Although research at present does not directly link BPA exposure to the development of autoimmune diseases, a large body of evidence supports the pro-inflammatory effects of BPA on the immune system. Further studies are required to elucidate the role of BPA in autoimmune pathogenesis, however caution should be taken in the use of BPA containing products by those affected or genetically susceptible to developing autoimmune diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Immunology

Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease

Maria Giovanna Danieli, Mario Andrea Piga, Alberto Paladini, Eleonora Longhi, Cristina Mezzanotte, Gianluca Moroncini, Yehuda Shoenfeld

Summary: The coronavirus disease-19 (COVID-19) pandemic caused by SARS-CoV-2 presents challenges globally, with a small percentage of patients progressing to severe or fatal involvement of multiple organs. Intravenous immunoglobulin (IVIg) treatment has shown benefits in reducing ICU stays, lowering mortality rates, and improving pulmonary function in critically ill patients with COVID-19.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2021)

Review Immunology

A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases

Maria Giovanna Danieli, Alessandro Tonacci, Alberto Paladini, Eleonora Longhi, Gianluca Moroncini, Alessandro Allegra, Francesco Sansone, Sebastiano Gangemi

Summary: This study evaluated the response to IVIg and 20%SCIg treatment using artificial intelligence in patients with IIM. AI techniques, such as machine learning and deep learning, were employed to analyze data and identify predictors for treatment response. The results showed that the presence of dysphagia and skin disorders, as well as the myositis activity index (MITAX) at the beginning of treatment, were associated with muscle strength as evaluated by MMT8 score at follow-up. The study suggests that Elastic Net and similar approaches are effective in predicting the clinical outcome in myositis.

AUTOIMMUNITY REVIEWS (2022)

暂无数据